AzTrials
AzTrials

Kangaroo CareNCT06195410

The Effect of Mother and Father Kangaroo Care on Newborn and Parent Outcomes in Premature Infants

A study testing kangaroo care application in people with Kangaroo Care, run by Selcuk University at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

First aim is to determine the effect of mother and father kangaroo care on the premature baby's Comfort Behavior level and physiological parameters (respiratory rate, heart rate, oxygen saturation and body temperature). Read more about this study

Who is it for?
Ages 26 to 37 weeksHealthy volunteers can take part
Conditions the study is for
Kangaroo Care
What is being tested?
kangaroo care application
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
38 participants
Where
2 sitesTurkey (Türkiye)
Study dates
18 Feb 2023to 18 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 26 to 37 weeks
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • For premature infants;
  • The baby is born before 36+6 weeks of gestation Stability of vital parameters at the time of application, Stable health status (cardiorespiratory stability, no congenital or chromosomal abnormalities, no history of intraventricular hemorrhage, no history of periventricular leukomalacia and NEC, no systemic and metabolic disorders),
  • For parents;
  • Willingness to participate in the research
  • Being able to read and write Turkish

Who cannot join

  • For premature infants;
  • Being connected to a mechanical ventilator
  • Congenital or chromosomal abnormality
  • Being with deprivation syndrome
  • Having a history of intraventricular hemorrhage
  • For parents:
  • Not being willing to care for kangaroos
  • Having a physical disability to care for kangaroos

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Selcuk University

    Konya, Selcuklu, 42060

  • Selcuk University

    Konya

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Mother and Father Kangaroo Care on Newborn and Parent Outcomes in Premature Infants: A Randomized Cross Over Study

First aim is to determine the effect of mother and father kangaroo care on the premature baby's Comfort Behavior level and physiological parameters (respiratory rate, heart rate, oxygen saturation and body temperature). Second aim is to determine the effect of mother and father kangaroo care on Parental Satisfaction and Neonatal Intensive Care Parental Stress level.

The study was a a randomized crossover study with pretest-posttest design. It was carried out in the neonatal intensive care unit of Selçuk University Faculty of Medicine Hospital in Konya province. Study data were collected from 19 mother and 19 father and their premature newborns between February 2023 and August 2023.

Read the detailed description

In the study, the mother applied kangaroo care to her premature baby for 65 minutes, and after a 24-72 hour washout period, the father applied kangaroo care for 65 minutes. The order of mother and father application was determined randomly.

Data were collected using Physiological Parameters Form, Neonatal Comfort Behavior Scale, Parental Satisfaction Scale and Neonatal Intensive Care Unit Parental Stress Scale.

In the study, physiological parameters and Neonatal Comfort Behavior Scale scores of premature infants and Neonatal Intensive Care Unit Parental Stress Scale and Parental Satisfaction Scale scores of parents were evaluated. Pearson Chi-Square Test, Yates Correction and Fisher's Exact Test were used to compare categorical data according to groups. Two Independent Sample t Test was used to compare normally distributed variables and Mann Whitney U Test was used to compare non-normally distributed variables. Statistical significance level was accepted as p˂0.05.

Conditions
Kangaroo Care
Being tested
kangaroo care application
Keywords
Mother Kangaroo Care, Father Kangaroo Care, Cross Over Study

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • kangaroo care applicationOther

    In the study, the mother applied kangaroo care to her premature baby for 65 minutes, and after a 24-72 hour washout period, the father applied kangaroo care for 65 minutes.

Study groups in NCT06195410
Study groupRoleWhat they receive
Comparator: Intervention GroupActive comparatorNot described
Receives: Other: kangaroo care application
ComparatorSham comparatorNot described
Receives: Other: kangaroo care application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physiological parameters of the premature infant:respiration rate

    The infant's is respiratory rate per minute.

    Measured: Change from baseline, 30min, and 65 min

  2. Physiological parameters of the premature infant:peak heart rate

    The infant's is heart rate per minute. Philips IntelliVue MP40 device was used to monitor heart rete.

    Measured: Change from baseline, 30min, and 65 min

  3. Physiological parameters of the premature infant: oxygen saturation

    Oxygen saturation measures the percentage of oxyhemoglobin (oxygen-bound hemoglobin) in the blood, and it is represented as arterial oxygen saturation (SaO2) and venous oxygen saturation (SvO2). Philips IntelliVue MP40 device was used to monitor %SpO2.

    Measured: Change from baseline, 30min, and 65 min

  4. Physiological parameters of the premature infant: body temperature

    Shows body temperature.

    Measured: Change from baseline, 30min, and 65 min

  5. Comfort Behavior scale scores of the premature infant

    Comfort Behavior scale was used. The Neonatal Comfort Behavior Scale (NEAS) is a Likert-type scale consisting of six parameters: alertness, calmness/agitation, respiratory response, crying, body movements, facial tension, and muscle tone. Each item in the scale is scored from 1 to 5. It is evaluated over the total score. The lowest score that can be obtained from the Newborn Comfort Behavior Scale (NEAS) is 6, and the highest score is 30.

    Measured: Change from baseline, 30min, and 65 min

  6. Parent Satisfaction points

    Parental Satisfaction scale was used. This scale was developed to assess parents' satisfaction in NICU. EMPATHIC-30 scale, 1= definitely not; 6 = absolutely yes and consists of five sub-dimensions; information (5 items), care and treatment (8 items), organization (5 items), parent involvement (6 items) and the professional attitude of the staff (6 items). One point represents the lowest satisfaction, while 6 points represents the highest satisfaction.

    Measured: baseline and 70 min

  7. Neonatal Intensive Care Unit Parental Stress Scale points

    Neonatal Intensive Care Unit Parental Stress Scale was used.The scale is a 34-item Likert-type scale with three subscales (Sights and Sounds, Infant Behavior and Appearance, and Parental Role Changes). Responses to the scale rate parents' stress level for each item from 1 (not at all stressful) to 5 (very stressful). As the scale score increases, stress increases.

    Measured: baseline and 70 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2024
  2. Study start18 Feb 2023
  3. Primary completion12 Jun 2023
  4. Study completion18 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06195410
Sponsor's protocol ID
SelcukU-12c-2023
Status last verified
Jan 2024
First submitted
22 Dec 2023
Last updated
10 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing kangaroo care application in people with Kangaroo Care, run by Selcuk University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physiological parameters of the premature infant:respiration rate (time frame: Change from baseline, 30min, and 65 min). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in